Trial intelligence / Profile preview

Alectinib rollover study in ALK-positive or RET-positive cancer

2017-000207-24Phase 3Completed

Sponsor

Roche

Start

Mar 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1